Veterinary Medicines

Kefavet® vet 500 mg, film-coated tablet

Authorised
  • Cefalexin monohydrate
Download as PDF

Product identification

Medicine name:
Kefavet® vet 500 mg, film-coated tablet
Kefavet vet. 500 mg apvalkotās tabletes suņiem
Active substance:
  • Cefalexin monohydrate
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Cefalexin monohydrate
    526.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Film-coated tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01DB01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Latvia
Available in:
  • Latvia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Orion Corporation
Marketing authorisation date:
Manufacturing sites for batch release:
  • Orion Corporation
Responsible authority:
  • Food And Veterinary Service
Authorisation number:
  • V/MRP/10/0023
Date of authorisation status change:
Reference member state:
  • Sweden
Procedure number:
  • SE/V/0114/002
Concerned member states:
  • Belgium
  • Czechia
  • Denmark
  • Estonia
  • Hungary
  • Iceland
  • Latvia
  • Lithuania
  • Luxembourg
  • Netherlands
  • Poland
  • Romania
  • Slovakia
  • Slovenia

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Latvian (PDF)
Published on: 16/04/2025
Download

Package Leaflet

English (PDF)
Published on: 17/04/2025
Download

Summary of Product Characteristics

English (PDF)
Published on: 17/04/2025
Download

Labelling

English (PDF)
Published on: 17/04/2025
Download